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Neal N. Sawlani, MD, Deepak L. Bhatt, MD, MPHS tarting with quantitative coronary analysis inthe 1980s (1), several methods to improve onvisual assessments of coronary lesions have
been developed, including intravascular ultrasound
and near-infrared spectroscopy (2–5). In recent years,
optical coherence tomography (OCT) has gained
popularity for its high spatial resolution and ability
to discriminate plaque characteristics and stent scaf-
folds with great detail (6,7). The adoption of OCT
into daily clinical practice, however, has been
limited. This is at least in part due to the lack of
long-term outcomes data on OCT use in percutaneous
coronary intervention (PCI). Perhaps an equally large
deterrent is the conundrum faced by clinical opera-
tors when confronted with the potentially abnormal
ﬁndings that are unmasked by OCT after stent
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to the contents of this paper to disclose.situation, large clinical studies are needed to clarify
the expected standards of stent optimization for
interventionalists.
The multicenter CLI-OPCI (Centro per la Lotta
contro l’Infarto–Optimisation of Percutaneous Coro-
nary Intervention) registry was an observational
study comparing the use of frequency domain OCT
with angiographic guidance for PCI (8). In a previous
study, 335 consecutive patients undergoing PCI with
post-procedural OCT at 3 Italian centers between
2009 and 2011 were matched with 335 patients un-
dergoing angiography-guided PCI alone during the
same month. OCT led to additional interventions in
34.7% of case subjects and a reduction in the primary
endpoint of cardiac death or myocardial infarction at
12 months (from 13.0% to 6.6%) in the OCT group (p ¼
0.006). This previous retrospective study generated
the foundation for the authors to analyze speciﬁc
end-of-procedure OCT ﬁndings and their association
with subsequent clinical outcomes.SEE PAGE 1297In this issue of iJACC, Prati et al. (9) have carefully
evaluated 984 lesions using pre-speciﬁed OCT criteria
to determine their impact on major adverse cardiac
events over a median follow-up of 319 days. The use
of OCT was left to the operator’s discretion. It is
therefore important to note the wide spectrum of
patients included: 56.4% of patients presented with
an acute coronary syndrome; ST-segment elevation
myocardial infarction was present in 31.0%; approxi-
mately 75% of all lesions were Ellis class B2/C; and
71.4% were treated with drug-eluting stents. OCT
images and clinical endpoints were adjudicated by
a core laboratory and clinical events committee,
respectively. A wide range of anatomical ﬁndings
were considered: edge dissection, reference lumen
narrowing, malapposition, in-stent minimum lumen
area, in-stent minimum lumen area <70% of the
average reference lumen area, and intrastent plaque
or thrombus protrusion. Taken together, at least 1 of
these variables occurred in 31.0% of cases and was
deﬁned as suboptimal stent implantation.
FIGURE 1 Normal OCT Image of a Stented Coronary Artery
Optical coherence tomography (OCT) can reveal an assortment of
angiographically absent ﬁndings, some of which may suggest
suboptimal stent implantation.
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1307Interestingly, suboptimal stent implantation was
independently associated with major adverse cardiac
events (MACE) within 1 year: 59.2% of patients
experiencing MACE had suboptimal stent implanta-
tion, whereas 26.9% of patients not experiencing
MACE had suboptimal stent implantation (p < 0.001)
(9). The majority of MACE occurred within 3 months
after PCI. Patients with suboptimal stent deployment
also had signiﬁcantly higher rates of target vessel
revascularization and stent thrombosis. Most impor-
tantly, this study was able to determine the ﬁndings
on OCT that independently predicted MACE. In-stent
minimum lumen area <4.5 mm2, distal edge dis-
section >200 mm, and reference vessel narrowing
each predicted adverse events. It is necessary to
acknowledge, however, that more than one-fourth of
patients without MACE at 1 year still had OCT-deﬁned
suboptimal stent implantation.
As noted earlier, at the end of PCI, the prevalence
of suboptimal stent implantation identiﬁed by the
core laboratory in this study was 31.0% (9). This
striking result begs the question of whether OCT
performed at the end of a procedure should prompt
any further intervention. OCT has clearly proven its
sensitivity for detecting abnormalities, but it is difﬁ-
cult to know how operators should interpret these
results. The high percentage of abnormal ﬁndings
identiﬁed in this study suggests that further treat-
ment with balloon angioplasty or overlapping stents
may still be followed by additional ﬁndings on OCT of
suboptimal stent implantation. Without prospectiverandomized data to guide them, operators will remain
unsure about what to do with all but the most glaring
OCT abnormalities.
In this regard, the study’s design (9) warrants some
key considerations. This was a nonrandomized sam-
ple, and the use of OCT was left to the operator’s
discretion. The potential exists for selection bias,
with the use of OCT in cases of less complex anatomy
and only in selected cases of emergency PCI. Without
randomization, it is also unclear what the impact of
differences in baseline patient characteristics and
their inﬂuence on PCI treatment strategy made on the
observed outcomes. Performing OCT after PCI seems
to have an excellent safety proﬁle; the selection of
patients, however, may have favored a wider margin
of error for device malfunction or deliverability.
Nevertheless, Prati et al. (9) performed a thorough
multivariable adjusted analysis, taking into consider-
ation several patient and lesion characteristics. Con-
sistent with intravascular ultrasound data (10),
signiﬁcant residual reference segment stenosis de-
monstrated the strongest association with MACE, with
an adjusted hazard ratio of approximately 5. The abil-
ity to correlate OCTmeasurementswith a higher rate of
long-term MACE is of great potential importance.
These cutoff values representing suboptimal stent
implantation should be tested in prospective trials.
Indeed, randomized clinical trials of routine OCT
use versus usual care are the next necessary step.
Otherwise, OCT risks being relegated to a niche pro-
cedure, much like intravascular ultrasound; this pro-
cedure has similarly remarkable observational data
supporting its routine use but it never attained the
higher threshold of deﬁnitive randomized clinical trial
data (5,11,12). For now, if OCT uncovers signiﬁcant
underexpansion or malapposition of a stent, a balloon
post-dilation is likely warranted; however, the best
option for a very small, nonobstructive stent edge
dissection not appreciated on multiple angiographic
views may be to do nothing. Eventually, revasculari-
zation strategies may vary based on the ability of OCT
to unveil speciﬁc lesion characteristics that are pre-
dictive of outcomes after PCI (NCT02337348 and
NCT01743274), hopefully including long-term clinical
endpoints. The cost-effectiveness of such a strategy
would also need to be evaluated. Until that time, it is
reassuring to decipher which of the many ﬁndings on
OCT after PCI deserve our immediate attention.
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